Compared with NAFL patients, the area under the receptor operating characteristic (AUROC) of pyroglutamate levels in NASH was larger than that of adiponectin, interleukin-8 and tumor necrosis factor alpha. This evidence concerns the gene CXCL8 and metabolic dysfunction-associated steatohepatitis.